Loading...
Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: A Consecutive Patient Series that Illustrates the Need for Rigorous Palliative Trials
PURPOSE: Rash is the most common side effect of epidermal growth factor receptor (EGFR) inhibitors and negatively impacts quality of life. This single-institution study sought to explore how rash is currently managed outside a clinical trial setting and to further characterize general clinical aspec...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Mary Ann Liebert, Inc.
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3037800/ https://ncbi.nlm.nih.gov/pubmed/21226620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jpm.2010.0258 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|